← Back to all news
← Terug naar alle nieuws
← Back to all news (FR)

Mithra successfully raises funds via an accelerated bookbuild offering

Mithra successfully raises funds via an accelerated bookbuild offering

Mithra successfully raises funds via an accelerated bookbuild offering

18/06/2020

Mithra has successfully raised an amount of EUR 65.0 million in gross proceeds by means of a private placement via an accelerated bookbuild offering.

Mithra is a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause.

The funds will be used to support the ramp-up of expenses related to the Phase 3 trial of Donesta®, working capital needs such as API and excipients purchases for the safety stock of hormonal contraceptive ring Myring™ and oral contraceptive pill Estelle®, further funding of the R&D pipeline such as neuroprotection and wound healing, and general corporate purposes.

Full press release: https://investors.mithra.com/wp-content/uploads/2020/06/2020-06-18-Mithra-Successfully-Raises-EUR-65-Million-EN.pdf

Picture source: Dries Luyten